Status:
UNKNOWN
Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy
Lead Sponsor:
Peking University First Hospital
Conditions:
Postoperative Pain
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
to compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy.
Detailed Description
To compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy, by using patient controlled analgesia postoperatively, a randomized, double blind clinical tri...
Eligibility Criteria
Inclusion
- elective Laparoscopic myomectomy patients 24hr post-operative patient controlled analgesia analgesia no mild or severe liver or renal disfunction
Exclusion
- can't understand patient controlled analgesia device refuse trial
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2018
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03288428
Start Date
May 1 2017
End Date
December 31 2018
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First hospital Peking University
Beijing, Beijing Municipality, China